Sionna Therapeutics
Steve Altmann is a Principal Scientist at Sionna Therapeutics, a position held since February 2020, following a tenure as Senior Scientist at the same organization. Prior to joining Sionna Therapeutics, Steve served as a Scientist at Sanofi from December 2014 to January 2020 and as a Sr. Associate Scientist at Amgen from May 2006 to October 2014. Steve holds a Master of Science degree in Molecular Biology from the University of Maine, obtained between 1998 and 2003.
Sionna Therapeutics
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).